BridgeBio Oncology Therapeutics (BBOT) Change in Account Payables (2024 - 2026)
BridgeBio Oncology Therapeutics (BBOT) posted Change in Account Payables of $10.7 million for Q1 2026, up 542.08% sequentially from -$2.4 million in Q4 2025, and up 1889.76% YoY from $537000.0 in Q1 2025.
BridgeBio Oncology Therapeutics (BBOT) Change in Account Payables (2024 - 2026) Analysis & Trends
BridgeBio Oncology Therapeutics has reported Change in Account Payables for 3 years, with the latest figure at $10.7 million in Q1 2026.
- Quarterly Change in Account Payables rose 1889.76% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.3 million (changed N/A YoY) and the FY2025 annual result came in at -$1.8 million, down 173.66% from the prior year.
- Change in Account Payables advanced to $10.7 million in Q1 2026 per BBOT's latest filing, from -$2.4 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $10.7 million in Q1 2026 and troughed at -$2.4 million in Q4 2025.
- A 3-year average of $1.8 million and a median of $537626.0 in 2025 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2025 and 2026: Change in Account Payables slumped 223.63% in 2025, then soared 1889.76% in 2026.
- Over 3 years, Change in Account Payables stood at $2.0 million in 2024, then plunged by 223.63% to -$2.4 million in 2025, then jumped by 542.08% to $10.7 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $10.7 million, -$2.4 million, and $538252.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | BridgeBio Oncology Therapeutics | 726.38 Mn | 500.67 Mn | - | -5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.33 Mn |
| Jun 30, 2026 | -5.33 Mn |
| Mar 31, 2026 | 10.69 Mn |
| Mar 31, 2026 | 10.69 Mn |
| Dec 31, 2025 | -2.42 Mn |
| Dec 31, 2025 | -2.42 Mn |
| Sep 30, 2025 | 538,252.00 |
| Sep 30, 2025 | 538,252.00 |
| Jun 30, 2025 | -498,252.00 |
| Jun 30, 2025 | -498,252.00 |
| Mar 31, 2025 | 537,000.00 |
| Mar 31, 2025 | 537,000.00 |
| Dec 31, 2024 | 1.96 Mn |
| Dec 31, 2024 | 1.96 Mn |